-
Company Insights
Innovation and Patenting activity of LEO Group Co Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of LEO Group Co Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Temtokibart in Atopic Dermatitis (Atopic Eczema)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Temtokibart in Atopic Dermatitis (Atopic Eczema) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Temtokibart in Atopic Dermatitis (Atopic Eczema) Drug Details: Temtokibart...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LEO-152020 in Chronic Urticaria Or Hives
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LEO-152020 in Chronic Urticaria Or Hives report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LEO-152020 in Chronic Urticaria Or Hives Drug Details: LEO-152020 is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Delgocitinib in Atopic Dermatitis (Atopic Eczema)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Delgocitinib in Atopic Dermatitis (Atopic Eczema) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Delgocitinib in Atopic Dermatitis (Atopic Eczema) Drug Details: Delgocitinib (Corectim)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Delgocitinib in Alopecia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Delgocitinib in Alopecia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Delgocitinib in Alopecia Drug Details: Delgocitinib (Corectim) acts as anti-allergic agent. It is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Delgocitinib in Psoriasis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Delgocitinib in Psoriasis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Delgocitinib in Psoriasis Drug Details: Delgocitinib (Corectim) acts as anti-allergic agent. It is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Delgocitinib in Hand Dermatitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Delgocitinib in Hand Dermatitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Delgocitinib in Hand Dermatitis Drug Details: Delgocitinib (Corectim) acts as anti-allergic agent....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pacmilimab in Cervical Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pacmilimab in Cervical Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pacmilimab in Cervical Cancer Drug Details: CX-072 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Erenumab in Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Erenumab in Pain report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Erenumab in Pain Drug Details: Erenumab (Aimovig, Aerinex, Pasurta, Glaseeq) is a human...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Trabectedin in Ewing Sarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Trabectedin in Ewing Sarcoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Trabectedin in Ewing Sarcoma Drug Details: Trabectedin (Yondelis) is an anti tumor...